http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100844877-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_079a5b3eecbeb0e5fcc2e9b817b28c97 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2007-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9391435ebdf8c7da1c80fcf6f77ad2a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa2a0936e40d09eb3c3fe2c58d4db82 |
publicationDate | 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100844877-B1 |
titleOfInvention | Liver cancer diagnosis using RERG |
abstract | The present invention relates to a kit for diagnosing human liver cancer, comprising a primer or probe specifically binding to a Ras-related, estrogen-regulated and growth-inhibitory (RERG) gene sequence, or an antibody specifically binding to a RERG protein. . The present invention first identified a gender-dependent correlation between the expression of the RERG gene and liver cancer. That is, the present invention relates to the diagnosis of liver cancer using the expression of the RERG gene appears as a high expression in liver cancer males, and a low expression in liver cancer women, and can accurately and easily diagnose liver cancer according to gender.n n n n RERG, liver cancer, cancer, sex |
priorityDate | 2007-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 459.